IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10751362 B1

PDFFull Text
Date of Patent:
Aug. 25, 2020

Filed:

Jul. 17, 2017

Compositions and methods for managing digestive disorders and a healthy microbiome

Applicant:

Metagenics, Inc., Aliso Viejo, CA (US);

Inventors:

Sara LeBrun-Blashka, Grafton, WI (US);

John Troup, Aliso Viejo, CA (US);

Nikhat Contractor, Aliso Viejo, CA (US);

Assignee:

METAGENICS, INC., Aliso Viejo, CA (US);

Attorney:

Warner Norcross + Judd LLP

Primary Examiner:

Dale R Miller

Int. Cl.
CPC ...
A61K 31/715 (2006.01); A61K 31/702 (2006.01); A23L 33/00 (2016.01); A23L 33/16 (2016.01); A23L 33/115 (2016.01); A23K 20/158 (2016.01); A23L 33/17 (2016.01); A23L 33/15 (2016.01); A23L 33/175 (2016.01); A23L 33/18 (2016.01); A23K 20/174 (2016.01); A23K 20/20 (2016.01); A23K 20/142 (2016.01); A23L 33/21 (2016.01); A23L 2/52 (2006.01); A61K 9/00 (2006.01); A61K 31/07 (2006.01); A61K 31/197 (2006.01); A61K 31/198 (2006.01); A61K 31/28 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/401 (2006.01); A61K 31/405 (2006.01); A61K 31/4172 (2006.01); A61K 31/4188 (2006.01); A61K 31/4415 (2006.01); A61K 31/455 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/555 (2006.01); A61K 31/593 (2006.01); A61K 31/7016 (2006.01); A61K 31/714 (2006.01); A61K 33/18 (2006.01); A61K 33/30 (2006.01); A61K 33/32 (2006.01); A61K 33/34 (2006.01); A61K 38/16 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/715 (2013.01); A23K 20/142 (2016.05); A23K 20/158 (2016.05); A23K 20/174 (2016.05); A23K 20/20 (2016.05); A23L 2/52 (2013.01); A23L 33/115 (2016.08); A23L 33/15 (2016.08); A23L 33/16 (2016.08); A23L 33/17 (2016.08); A23L 33/175 (2016.08); A23L 33/18 (2016.08); A23L 33/21 (2016.08); A23L 33/40 (2016.08); A61K 9/0056 (2013.01); A61K 9/0095 (2013.01); A61K 31/07 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/28 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/401 (2013.01); A61K 31/405 (2013.01); A61K 31/4172 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/525 (2013.01); A61K 31/555 (2013.01); A61K 31/593 (2013.01); A61K 31/702 (2013.01); A61K 31/7016 (2013.01); A61K 31/714 (2013.01); A61K 33/18 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01); A61K 38/168 (2013.01); A61K 45/06 (2013.01); A23V 2002/00 (2013.01);
Abstract

Disclosed is a prebiotic composition comprising a combination of 2'fucosyllactose (2′FL) and isomaltooligosaccharide (IMO). The 2′FL and IMO are present in the prebiotic composition in a weight ratio of from 1:1 to 1:10. The prebiotic composition is effective for use in methods of preventing and/or treating a gastrointestinal (GI) condition in an animal, such as irritable bowel syndrome (IBS), inflammatory bowel disease(s) (IBD), Crohn's disease, and ulcerative colitis (UC). A foodstuff or beverage, a medical food, a nutritional composition, and a kit presentation, each including the prebiotic composition, and each suitable for use in methods of reducing or suppressing inflammation in an animalian tract, are also disclosed. A method of using the prebiotic composition to prevent and/or treat a GI condition in an animal is further disclosed. The method comprises administering the prebiotic composition to the animal.

Find Patent Forward Citations

Loading…